Luisa Fofi

8PUBLICATIONS
38CO-AUTHORS
Gene and molecular therapyMedical infection agents (incl. prions)Epidemiological methodsDisease surveillancePain
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

|May 04, 2026
Effectiveness of an Oral Supplementation of Phycocyanin and Palmitoylethanolamide for a Short-Term Prophylaxis of Menstrual Migraine: A Retrospective Observational Study.

|Mar 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability.

Luigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis

|Feb 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano

|Dec 18, 2025
Introducing the four dimensions 4D migraine scale: A composite score proposal evaluating migraine severity and treatment efficacy.

Patrizio Pasqualetti, Claudia Altamura, Luisa Fofi

|Oct 17, 2025
The clinical outcome of patients starting monoclonal antibodies anti-CGRP with concomitant migraine preventive treatments.

Luisa Fofi, Claudia Altamura, Marilena Marcosano

Pageof 2

Frequent Collaborators

7 joint publications

Claudia Altamura

7 joint publications

Fabrizio Vernieri

6 joint publications

Luigi Francesco Iannone

4 joint publications

Simona Sacco